Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 5/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | AKT2 | P31751 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21667422 | 0.94 | TDP1 (0.49) | TDP1L3MBTL1KDM4EALDH1A1LMNA | |
| SCHEMBL15041040 | 0.94 | TDP1 (0.42) | TDP1L3MBTL1KDM4EALDH1A1LMNA | |
| SCHEMBL13614924 | 0.93 | KDM4E (0.47) | TDP1L3MBTL1KDM4EALDH1A1LMNA | |
| SCHEMBL21667598 | 0.92 | LMNA (0.39) | TDP1L3MBTL1KDM4EALDH1A1LMNA | |
| SCHEMBL13726419 | 0.90 | MAPK14 (0.49) | TDP1L3MBTL1KDM4EALDH1A1LMNA | |
| SCHEMBL12690524 | 0.90 | TDP1 (0.39) | TDP1L3MBTL1KDM4EALDH1A1LMNA | |
| SCHEMBL18996717 | 0.89 | TDP1 (0.44) | TDP1L3MBTL1KDM4EALDH1A1LMNA | |
| SCHEMBL14508285 | 0.88 | TDP1 (0.49) | TDP1L3MBTL1KDM4EALDH1A1LMNA | |
| SCHEMBL14508274 | 0.88 | TDP1 (0.49) | TDP1L3MBTL1KDM4EALDH1A1LMNA | |
| SCHEMBL13727997 | 0.88 | MAPK14 (0.53) | TDP1L3MBTL1KDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130285035-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, AND DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2013-10-31 | — | — | US | disclosed |
| US-20130285035-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, AND DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2013-10-31 | — | — | US | disclosed |
| US-20120193619-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND LIGHTING DEVICE USING SAME | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-08-02 | — | — | US | disclosed |
| US-20120193619-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND LIGHTING DEVICE USING SAME | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-08-02 | — | — | US | disclosed |
| US-7612204-B2 | Quinoxaline derivative, and light-emitting element and light-emitting device using quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| US-7612204-B2 | Quinoxaline derivative, and light-emitting element and light-emitting device using quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| US-7612204-B2 | Quinoxaline derivative, and light-emitting element and light-emitting device using quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| EP-2084138-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT AND LIGHT-EMITTING DEVICE USING QUINOXALINE DERIVATIVE | Semiconductor Energy Laboratory Co, Ltd. (JP) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008047589-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT AND LIGHT-EMITTING DEVICE USING QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-04-24 | — | — | WO | disclosed |
| WO-2008047589-A1 | QUINOXALINE DERIVATIVE, AND LIGHT-EMITTING ELEMENT AND LIGHT-EMITTING DEVICE USING QUINOXALINE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-04-24 | — | — | WO | disclosed |
| US-20080091012-A1 | Quinoxaline Derivative, And Light-Emitting Element And Light-Emitting Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-04-17 | — | — | US | disclosed |
| US-20080091012-A1 | Quinoxaline Derivative, And Light-Emitting Element And Light-Emitting Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-04-17 | — | — | US | disclosed |
| US-20080091012-A1 | Quinoxaline Derivative, And Light-Emitting Element And Light-Emitting Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080091012-A1 | Quinoxaline Derivative, And Light-Emitting Element And Light-Emitting Device Using Quinoxaline Derivative | NQO1, GLB1, PDXK | TDP1 2057/4885L3MBTL1 1370/4885KDM4E 2134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.